Mass Medical Angels (MA2) is a seed stage investor group exclusively focused on life science and healthcare investments. Their mission is to bring more clinical tools to the marketplace while attaining superior returns for their investors. They provide financing and mentoring to early-stage life-science companies, aiming to help them obtain further funding, reach positive cash flows, or get acquired. MA2 invests in medical devices, therapeutics, diagnostics, health services, health information technologies, and relevant research-related tools.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions